Alcohol Consumption, Left Atrial Diameter, and Atrial Fibrillation

J Am Heart Assoc, 14 September 2016 Background Alcohol consumption has been associated with atrial fibrillation (AF) in several epidemiologic studies, but the underlying mechanisms remain unknown. We sought to test the hypothesis that an atrial myopathy, manifested by echocardiographic left atrial enlargement, explains the association between chronic alcohol use and AF. … Conclusions Our study of a […]

Relation of Body Mass Index With Adverse Outcomes Among Patients With Atrial Fibrillation: A Meta-Analysis and Systematic Review

J Am Heart Assoc, 9 September 2016 Background Several studies have investigated the impact of body mass index (BMI) on the prognosis of atrial fibrillation, but the results remain controversial. We sought to estimate the association of BMI with atrial fibrillation–related outcomes. … Conclusions Underweight BMI is associated with an increased risk of stroke or systemic embolism, cardiovascular […]

Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis

BMJ, 6 September 2016 Objective To quantify the association between atrial fibrillation and cardiovascular disease, renal disease, and death. … Conclusions Atrial fibrillation is associated with an increased risk of death and an increased risk of cardiovascular and renal disease. Interventions aimed at reducing outcomes beyond stroke are warranted in patients with atrial fibrillation. Read more.

Atrial fibrillation

Lancet, 18 August 2016 Atrial fibrillation affects 33 million individuals worldwide,and increases the risk of stroke, heart failure, and death; it also impairs quality of life. The goals of care in atrial fibrillation include the prevention of stroke, control of the ventricular rate, and minimisation of symptoms to improve quality of life. A three-part clinical Series summarises […]

Ablation of Atrial Fibrillation: Patient Selection, Periprocedural Anticoagulation, Techniques, and Preventive Measures After Ablation

Circulation, 26 July 2016 Atrial fibrillation (AF) is the most common arrhythmia encountered by cardiologists and is a major cause of morbidity and mortality. Risk factors for AF include age, male sex, genetic predisposition, hypertension, diabetes mellitus, sleep apnea, obesity, excessive alcohol, smoking, hyperthyroidism, pulmonary disease, air pollution, heart failure, and possibly excessive exercise. The management of […]

2016 ACC/AHA Clinical Performance and Quality Measures for Adults With Atrial Fibrillation or Atrial Flutter: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures

Circ Cardiovasc Qual Outcomes, 27 June 2016 In the summer of 2015, the ACC/AHA convened the writing committee to begin the process of revising the existing atrial fibrillation (AF) and atrial flutter measure set that was released in 2008 and for which implementation notes had been issued in 2011. The writing committee also was charged with the […]

Patients With Ischemic Stroke and Incident Atrial Fibrillation: A Nationwide Cohort Study

Stroke, 6 August 2015 Background and Purpose—A substantial part of ischemic strokes is attributed to atrial fibrillation (AF). We hypothesized that patients with ischemic stroke without prior diagnosed AF were at higher risk of having a subsequent diagnosis of AF, and this was associated with multiple risk factors.… Conclusions—Ischemic stroke was associated with a substantially […]

Non–Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Asian Patients With Nonvalvular Atrial Fibrillation: Meta-Analysis

Stroke, 30 July 2015 Background and Purpose—The use of vitamin K antagonists (VKAs), the cornerstone treatment for stroke prevention in patients with atrial fibrillation, is limited by the perceived risk of serious bleeding in Asia. Non-VKA oral anticoagulants (NOACs) are safer alternatives. Here, we evaluate performance differences of NOACs between Asians and non-Asians.… Conclusions—Our findings […]

Treatment of Atrial Fibrillation

JAMA, 21 July 2015 Importance Atrial fibrillation is a common arrhythmia that affects more than 2.5 million people in the United States and causes substantial morbidity and mortality, especially regarding the increased risk of stroke. Objective To summarize atrial fibrillation treatment exclusive of stroke prevention.… Conclusions and Relevance Therapy for atrial fibrillation includes prevention and modification of inciting […]

Stroke and Bleeding Risk Associated With Antithrombotic Therapy for Patients With Nonvalvular Atrial Fibrillation in Clinical Practice

J Am Heart Assoc, 17 July 2015 Background The quality of antithrombotic therapy for patients with nonvalvular atrial fibrillation during routine medical care is often suboptimal. Evidence linking stroke and bleeding risk with antithrombotic treatment is limited. The purpose of this study was to evaluate the associations between antithrombotic treatment episodes and outcomes.… Conclusions Continuation […]

National Minority Quality Forum
Clinical Trial Engagement Network Map Childhood Obesity MapHIV Z-Atlas: Peripheral Arterial Disease Atlas Map Lung Cancer Index Z-Atlas: Chronic Kidney Disease AFIB Index Cardiometabolic Health Aliance Minority Diabetes Coalition U.S. Diabetes Index County Edition U.S. Diabetes Index Research Edition Medicare Index Medicare Index Stroke Edition About The Minority Stroke Working Group Hepatitis C Disease Index Lead Risk Index Map MRSA StrokePAD Minority Index The South Texas Diabetes Initiative Minority Stroke Consortium YouTube NMQF Videos IPAB Action Center National Health Index

© 2011 National Minority Quality Forum, Inc. All Rights Reserved.